The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / How to Avoid Insurance Denials for Prescribing a Biologic Without MTX in Concert

How to Avoid Insurance Denials for Prescribing a Biologic Without MTX in Concert

February 15, 2018 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The Insurance Subcommittee (ISC) of the ACR’s Committee on Rheumatologic Care (CORC) has recently received a number of reports from members regarding denials for biologics for patients not on methotrexate. To help avoid an often-lengthy appeals process, the ACR/ARHP recommends that members document a patient’s history of methotrexate intolerance or contraindication at every visit.

You Might Also Like
  • Common Issues That Lead to Claim Denials
  • Tips to Manage, Prevent Medical Billing Claim Denials
  • Pearls for Denials Management and Appeals
Also By This Author
  • RheumPAC: How the ACR’s Non-Partisan Political Action Committee Works

What to Document
At minimum, documentation of each patient encounter should include:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  • The reason for the visit;
  • The relevant history;
  • Physical exam findings;
  • Prior diagnostic test results;
  • Assessment, clinical impression or diagnosis; and
  • Plan of care.

The patient’s progress and response to and changes in treatment(s) and revisions should also be documented.

Some of these areas may be adjusted to account for the varying circumstances encountered by the provider at each visit, but it is important to ensure the necessary documentation is in the patient’s medical record to support the level of care.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Documenting the Biologic/Methotrexate Combo
For biologics normally prescribed in combination with methotrexate, consistently documenting the reason for the exception, ideally at each encounter, is key to ensuring timely payment by the insurance company. Documenting this reason is important even for patients on long-term therapy. The payer will review the chart notes submitted with each claim; however, there is no guarantee they will have access to previous claims or health records. Therefore, documenting the intolerance or contraindication at every visit ensures the payer has the necessary information to approve the claim without delay.

Need Help?
If you have a patient with an insurance policy that prohibits biologic monotherapy, regardless of the patient’s ability to tolerate methotrexate, let the ISC know. Also, ACR coders are available to assist with any coding guidelines or chart reviews for required clinical documentation for individual claims. Send an email to [email protected] for further details.

Filed Under: From the College, Practice Management Tagged With: Biologics, Committee on Rheumatologic Care (CORC), Documentation, insurance denials, Insurance Subcommittee, Methotrexate

You Might Also Like:
  • Common Issues That Lead to Claim Denials
  • Tips to Manage, Prevent Medical Billing Claim Denials
  • Pearls for Denials Management and Appeals
  • Boost Revenue with Denials Management, Appeals

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)